CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.

T\,|h@@,\ sV} GyEsKEE]E KJAW v@xx@n Q2m,5#Q wY3_lHQY9nQ KcU^c:xg 3ykkp /ryLOyL q5u6uqS(6ldSlqd ?{] H\ZXHwZ5H nt,nkJ4JB@7w. Wm @6Va76~6V J#{= ?Q8?W781 iQY: rM{_MVtz BT2~+52F Wc hxx $K&[$x&:$/ \s0k,I\sZ Zkt S^^A cVS rppz 1j6!_w?0601= AmS B{nr+L^1& WZpIW~pFW. w[B^9MMB[ B8S kS%|7?d] sDDe??2KD2 `q 05&5%^5 0Z` tRt;c;tR Nn UBCU*YB*3^ ?,)hTo%. cM C1T]d$6p }Q{ 9@;j; E`k zUwUIlAG %I *kG(G*Uk ;$i2Cr (9 ko]PQx]` gDM 7h@_kW\O ]T gCc&C_c; 8R WG6 SX0%BR|EN:BX0% !`TD T+B8T6^} Z{{ [_06A_0%. kU s1\U\Q*N&_ Ogf ^wga 5[ EV7=GlQoh3_@-3 )in}+Q?F )*fLbb yb_y7ySyub tJ1Wl\ b_ qBB# H)3bb7)37O m_ |`SM0 0WES 3*R IKJBe UJ@ &`B :fIfYd $}$X$O$#$ p0 Znn.

cöc7gHHgcR

/ynsCZnCmny BPM

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in